Glaucoma ranks as the second leading cause of irreversible but preventable blindness worldwide. (Image Credits: Pixabay) Akums Drugs & Pharmaceuticals Ltd. on Tuesday announced the launch of a ...
April 6, 2007 — Results of 2 randomized studies assessing a fixed-dose tablet combining sumatriptan and naproxen ( Trexima, Pozen Inc/GlaxoSmithKline) suggest that the combination offers more ...
Wu Xiaohui of Wanhuida Intellectual Property examines how a recent CNIPA decision reinforces the need for a holistic inventive step assessment when evaluating pharmaceutical combination formulations ...
Please provide your email address to receive an email when new articles are posted on . Melasma scores improved by 40%, 57% and 63% at days 30, 60 and 90, respectively. Adverse events were reported in ...
PHOENIX--(BUSINESS WIRE)--PanTheryx, an integrative digestive and immune health company, today announced the expansion of its formulation capabilities to now include colostrum plus probiotic ...
It is estimated that approximately half of patients take their medications improperly. In the United States alone, adherence problems result in estimated costs of up to $100 billion annually. This is ...
The results from the Phase 1b TRIMM-2 study evaluating talquetamab, the first bispecific T-cell engager to target GPRC5D, combined with daratumumab SC, the first subcutaneous anti-CD38 monoclonal ...
"The IV formulation of DARZALEX, which is approved in combination with pomalidomide and dexamethasone, is an important option for patients with multiple myeloma. We are excited to pursue the ...
Novel immunotherapy combination regimen brings together two complementary therapies to improve outcomes for people living with multiple myeloma as early as second line1 The application is supported by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results